Technological convergence, the coming together of technologies that were once unrelated to form newly integrated innovations or disciplines, is a concept that we all experience in our daily lives. Consider the example of the mobile devices we all carry today. This was the technological convergence of telephone, television, computer, camera, and others into a single package.
Such technological convergence does not only exist in our consumer lives. It is now increasingly becoming a necessity and reality within the biopharmaceutical industry!
As industry 4.0 principles are applied to and adopted in the biomanufacturing arena – also known as Biopharma 4.0 or Bioprocessing 4.0 – and innovative, digital technologies and approaches typically not used in the drug manufacturing landscape emerge, one could refer to this phenomenon as “convergent bioprocessing”.
This paradigm shift and digital transformation of biomanufacturing processes will result in a facility of the future that is truly an ecosystem of intensified, connected and continuous processing seamlessly coupled with uninterrupted data acquisition and analysis. Together, this will make real-time lot release and lights-out manufacturing achievable to the ultimate benefit of patients around the globe, expanding access to affordable and accessible lifesaving and life-enhancing biotherapeutics.
Convergent bioprocessing: Inspired by a passion for technological advancement, now brought to bioprocessing, made better by biomanufacturing scientists and engineers. It’s time to converge!